市场调查报告书
商品编码
1618253
泌尿系统设备:市场洞察·竞争环境·市场预测 (~2030年)Urology Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
泌尿器械市场规模预计将从 2023 年的 91.7 亿美元增长到 2030 年的 135.6 亿美元,预测期内复合年增长率为 6.78%。
泌尿设备市场的推动因素包括越来越多的癌症和良性前列腺增生 (BPH) 等慢性疾病患者、人口老龄化更容易患此类疾病、产品开发的技术进步以及对微创的偏好由于趋势的扩展,它已显着增长。
泌尿装置:市场动态
根据全球癌症观察站(2024)提供的数据,2022年欧洲将有473,011例前列腺癌病例,亚洲将有386,424例,拉丁美洲和加勒比海地区(LAC)将有225,985例,美洲将有225,985例。
此外,亚洲有417,357例直肠癌,欧洲有181,701例,拉丁美洲和加勒比海地区有43,036例,非洲有27,672例。
根据美国国立卫生研究院(2024) 的数据,目前全球良性前列腺增生的盛行率正在上升,在60 多岁的人群中达到50-60%,在70 岁以上的人群中达到80- 90%。
此外,世界卫生组织(2021)指出,2015 年至 2050 年间,60 岁及以上人口数量将从 12% 至 22% 翻一番,到 2050 年达到 21 亿。此外,据报道,到2030年,六分之一的人将超过60岁。
随着人口老化,前列腺癌、良性前列腺增生、直肠癌的盛行率不断增加,对泌尿器械产生了巨大的需求。这些疾病经常引起泌尿系统併发症,增加了对先进治疗方案的需求。由于医疗技术的创新和对改善患者治疗效果的日益关注,医疗保健系统正在优先考虑尿路阻塞的有效管理,这也有助于市场扩张。
按产品类型划分,透析设备领域预计将在 2023 年占据重要的收入占有率。该行业的快速成长归因于透析设备的特点。
先进的透析设备通常包括远端监控功能、即时数据收集以及各种治疗参数的自动化等功能,从而提高安全性和易用性。此外,对穿戴式透析设备的研究正在进行中,以增加患者的自由度并提高生活品质。透析设备的应用多种多样,不仅用于慢性肾臟病管理,还用于急性肾损伤、药物过量的紧急解毒,以及作为晚期肾臟病患者进行肾臟移植的桥樑。
按地区划分,北美地区在 2023 年占据市场主导地位,预计在预测期内将保持不变。这是由于肾结石的增加、前列腺癌患病率的增加以及对有效管理解决方案的需求不断增长,而技术进步、监管批准以及领先企业对医疗基础设施和创新产品开发的持续投资推动了这一趋势。
本报告提供全球泌尿系统设备的市场调查,彙整市场概要,市场影响因素及市场机会分析,法律制度,市场规模的转变·预测,各种区分·地区/各主要国家的详细分析,竞争情形,主要企业简介等资讯。
Urology Devices Market by Product Type (Dialysis Devices, Endoscopes [Ureteroscopes, Nephroscopes, Resectoscopes, and Others], Urodynamic Systems, Uretral Stents, and Others), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing cases of chronic disorders and the rising product developmental activities across the globe
The urology devices market was valued at USD 9.17 billion in 2023, growing at a CAGR of 6.78% during the forecast period from 2024 to 2030 to reach USD 13.56 billion by 2030. The urology devices market is growing significantly due to the increasing cases of chronic disorders including cancers and benign prostatic hyperplasia (BPH), rising geriatric population prone to such conditions, technological advancements in product development, growing preference of minimally invasive procedures that are expected to escalate the demand for urology devices during the forecast period from 2024 to 2030.
Urology Devices Market Dynamics:
According to the data provided by the Global Cancer Observatory (2024), in 2022, Europe accounted for 473,011 prostate cancer cases, Asia accounted for 386,424 prostate cancer cases, Latin American and the Caribbean (LAC) accounted for 225,985 prostate cancer cases, and Africa accounted for 103,050 prostate cancer cases.
Furthermore, it stated that Asia accounted for 417,357 rectum cancer cases, Europe accounted for 181,701 rectum cancer cases, LAC accounted for 43,036 rectum cancer cases, and Africa accounted for 27,672 rectum cancer cases.
According to the National Institute of Health (2024), the current prevalence of benign prostatic hyperplasia (BPH) is 50% to 60% for people in their 60s, increasing to 80% to 90% of those older than 70 years of age, globally.
Moreover, the World Health Organization (2021) further stated between 2015 and 2050, people falling between 60 years and above will be doubled from 12-22%, and will eventually reach 2.1 billion by the year 2050, globally. Moreover, by 2030, 1 in 6 people will be aged 60 years or above.
The increasing prevalence of prostate cancer, BPH, and rectal cancer, with aging populations, is creating a significant demand for urology devices. As these conditions often lead to urinary complications, the need for advanced treatment options is rising. The global aging trend, with more people reaching older age groups where these conditions are more common, further amplifies the market demand. Innovations in medical technology and a growing focus on improving patient outcomes are also contributing to the expansion of this market, as healthcare systems prioritize effective management of urinary tract obstructions.
Therefore, the factors stated above collectively will drive the overall urology devices market during the forecast period from 2024 to 2030.
However, the disruption of surrounding tissue associated with hematuria and risks of stone fragment retention, among others may limit their end-user base, thus acting as key constraints limiting the growth of the urology devices market.
Urology Devices Market Segment Analysis:
Urology Devices Market by Product Type (Dialysis Devices, Endoscopes [Ureteroscopes, Nephroscopes, Resectoscopes, and Others], Urodynamic Systems, Uretral Stents, and Others), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of urology devices, the dialysis devices category is expected to have a significant revenue share in the year 2023. The rapid growth of this product category can be attributed to the features of the dialysis devices.
Dialysis devices are essential medical equipment used to filter and purify blood for individuals whose kidneys can no longer perform these functions efficiently. The primary feature of dialysis devices is their ability to remove waste products, excess fluids, and toxins from the bloodstream, mimicking the natural functions of the kidneys.
Advanced dialysis machines often include features like remote monitoring capabilities, real-time data collection, and automation of various treatment parameters, enhancing safety and ease of use. Additionally, wearable dialysis devices are being explored to offer patients more freedom and improved quality of life. Applications of dialysis devices extend beyond chronic kidney disease management to include use in acute kidney injury, emergency detoxification for drug overdose cases, and as a bridge to kidney transplant for end-stage renal disease patients.
Therefore, owing to the above-mentioned factors, the demand for the dialysis devices category upsurges, thereby the category is expected to witness considerable growth eventually contributing to the overall growth of the urology devices market during the forecast period from 2024 to 2030.
North America is expected to dominate the overall urology devices market:
Among all the regions, North America is expected to dominate the urology devices market in the year 2023 and is expected to do the same during the forecast period from 2024 to 2030. This is due to the increasing instance of kidney stones, growing prevalence of prostate cancer underscoring the increased demand for effective management solutions, enhanced by technological advancements, regulatory approvals, and significant market presence of leading companies, continued investment in healthcare infrastructure and innovative product developments that are expected to drive the market for urology devices during the forecast period from 2024 to 2030.
According to the American Urological Association (2024), nearly 1 in 11 individuals in the US experience kidney stone at some point in their lives, and evidence suggests that the incidence of kidney stones is increasing.
According to Globocan (2024), in 2022, the US accounted for 230,125 cases of prostate cancer and Canada accounted for 25,560 cases of prostate cancer. Additionally, it further stated that by 2050, prostate cancer will reach to 346,000 cases in the North American region.
The rising incidence of kidney stones and prostate cancer is driving the demand for urology devices. As more individuals experience these conditions, there is a growing need for effective interventions to manage urinary blockages, making this a rapidly expanding market.
Additionally, in North America and at the global level the US represents the largest market worldwide supported by the developed healthcare infrastructure and strong adoption of technologically advanced products owing to the rise in healthcare expenditure by the government.
Rising product developmental activities by regulatory bodies in the region will further boost the market for urology devices. For example in April 2024, Olympus Corporation announced the FDA 510(k) clearance for its RenaFlex single-use ureteroscope system. RenaFlex offers access and visualization in the urinary tract to diagnose and treat urinary diseases and disorders, such as kidney stones.
Moreover, the presence of key players such as Boston Scientific Corporation, B. Braun Melsungen AG, Cook, among others in the region with their strong distribution networks ensure widespread availability and accessibility of these devices increasing their revenue shares in the market is also a driving factor for the urology devices market as they hold a significant revenue share in the region.
Therefore, the interplay of all the aforementioned factors above would provide a conducive growth environment for the North America region in the urology devices market.
Urology Devices Market key players:
Some of the key market players operating in the Urology Devices market include Olympus Corporation, Baxter, Boston Scientific Corporation, B. Braun Melsungen AG, Nipro Corporation, Medtronic, Cook, BestMedical, Potent Medical, Laborie, Well Lead Medical Co.,Ltd, Amecath Medical Technologies, NIKKISO CO., LTD, Asahi Kasei Medical, Applied Medical Resources Corporation, Advin Urology, DirexGroup, STORZ MEDICAL AG, Richard Wolf GmbH, Fresenius Medical Care, and others.
Recent Developmental Activities in the Urology Devices Market:
Key Takeaways from the Urology Devices Market Report Study
Target audience who can be benefited from this Urology Devices Market Report Study
Frequently Asked Questions for the Urology Devices Market: